Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Heinrich-Heine University, Duesseldorf
With
German Federal Ministry of Education and Research
German Research Network On Schizophrenia
Janssen-Cilag Ltd.
University of Bonn
Humboldt-Universität zu Berlin
University of München
University of Göttingen
University of Cologne
Mainz University
University Hospital Tuebingen
Universität Duisburg-Essen
University of Mannheim
University of Jena
Martin-Luther-Universität Halle-Wittenberg
RWTH Aachen University
University of Wuerzburg
The objective of this multi-center study is to optimize the long-term treatment of patients with first episode schizophrenia. This investigation should contribute to the issue of effective relapse prevention in first-episode patients. 1-year maintenance neuroleptic treatment is done with low dose haloperidol or risperidone (target dose 2-4 mg/die).
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
After the acute treatment of the first-episode in schizophrenia (according ICD-10 F20)
Age between 18 and 55
Informed consent
You may not be if
Residence outside of the catchment area
Legal reasons
Insufficient knowledge of the German language
Substance abuse or addiction
Pregnancy
Serious physical illness
Organic brain disease
Contraindication to neuroleptic treatment
Clareo Health | One Year Drug Treatment in First-Episode Schizophrenia
